PARIS, June 30, 2022 — Atos, in agreement with the Wellcome Genome Campus in Cambridgeshire, UK, has announced the official opening of its global Life Sciences Centre of Excellence. The facility will provide scientists on campus, and global genome and bio-data institutes worldwide, early access to emerging technologies to support their research, helping to accelerate the process of bringing new drugs to market and delivering tangible societal benefits.
The Atos Life Sciences Centre of Excellence is an exploration, discovery and co-creation instrument aimed at complementing the existing Campus compute facilities with access to leading-edge technologies, such as Quantum, High-Performance Computing, Edge Computing and AI, supported by Atos’ products, services and expertise in these sectors. The facility will also feature leading-edge technologies from Atos partners including Arm, Intel, and NetApp. First established during the Covid-19 confinement crisis, this center provided support to researchers worldwide studying many different aspects of the virus.
Atos experts world-wide will collaborate directly with genome and biological data research scientists to help transform ideas into reality, focusing specifically on enabling the implementation of precision health and accelerating drug development using digital technologies. The aim is to create solutions that enable healthcare organizations to design efficient strategies to prevent and manage disease and to support pharma/biotech and medtech organizations in in accelerating the development of targeted treatments/cutting edge medical equipment and sensors, helping to tackle the greatest health challenges in society today.
The outcomes from collaboration between Atos and health and life sciences stakeholders will be showcased at the Centre of Excellence through innovation workshops, proof-of-concept production, demos and webinars.
“The opening of the Life Sciences Centre of Excellence is a significant milestone in Atos’ pioneering work to drive innovation in the healthcare and life sciences industry,” said Dr Natalia Jimenez, Global Life Sciences Product Lead, Atos. “By providing an ecosystem where genome and biological data research scientists can access emerging technologies accompanied by leading Atos experts, the Centre of Excellence will play a crucial role in fostering life sciences discovery and innovation, expediting the time it takes to bring new drugs to market and delivering tangible benefits to patients.”
“We are delighted that Atos has joined our Campus community, and look forward to partnering with them to maximize the vast range of opportunities the Centre of Excellence will provide for scientists here and worldwide,” commented Dr. Julia Wilson, Associate Director, Wellcome Sanger Institute. “Emerging technologies such as Quantum, High-Performance Computing, Edge Computing and AI hold transformative potential for advancing biodata research, helping the life sciences sector to shorten the drug development process and reduce costs.”
Atos is a global leader in digital transformation with 111,000 employees and annual revenue of c. € 11 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all industries in 71 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos is a SE (Societas Europaea), listed on Euronext Paris and included in the CAC 40 ESG and Next 20 Paris Stock indexes.